查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1709464

醫藥分析測試外包市場，按服務類型、按測試類型、按最終用戶、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Pharmaceutical Analytical Testing Outsourcing Market, By Service Type, By Testing Type, By End-User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年，醫藥分析測試外包市場規模價值 85.3055 億美元，2025 年至 2032 年的複合年成長率為 7.70%。

醫藥分析測試外包市場-市場動態

學名藥市場的擴張推動了分析測試需求

學名藥市場的擴張是推動醫藥分析測試外包市場發展的重要動力。隨著全球（尤其是北美）對平價藥物的需求不斷成長，製藥公司越來越注重開發學名藥，這需要嚴格的分析測試以確保品質和法規遵循。學名藥行業受益於較低的生產成本，而外包分析測試可以讓公司在控制費用的同時保持高標準。此外，將學名藥快速推向市場的壓力越來越大，進一步推動了外包的需求，因為第三方測試提供者可以提供速度和專業知識。根據美國 FDA 統計，美國超過 90% 的處方藥都是學名藥，凸顯了龐大的市場規模以及對可靠、高效檢測的需求。預計這一趨勢將持續下去，並在未來幾年推動對合約測試服務的需求。

醫藥分析測試外包市場-關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 7.70%。

根據服務類型細分，預計品質控制測試將在 2024 年佔據最大市場佔有率

根據測試類型細分，成品測試是 2024 年領先的測試類型

根據最終用戶細分，製藥公司是 2024 年領先的最終用戶

按地區分類，北美是 2024 年的主要收入來源

醫藥分析測試外包市場-細分分析：

全球製藥分析測試外包市場根據服務類型、測試類型、最終用戶和地區進行細分。

根據服務類型，市場分為六類：品質控制測試、生物分析測試、穩定性測試、方法開發和驗證、監管測試和微生物測試。在製藥分析測試外包市場中，品質控制測試是最重要且最主要的部分。這是因為它在確保藥品在進入市場之前符合所需的安全性、有效性和品質標準方面發揮關鍵作用。品質控制測試在整個藥物開發過程中是強制性的，對於遵守法規至關重要，這使其成為製藥業外包的重點。對高品質、可靠產品的需求不斷成長，推動了對這些服務的持續需求，進一步鞏固了其突出地位。

根據測試類型，市場分為四大類：原料測試、成品測試、臨床試驗測試和包裝測試。在醫藥分析測試外包市場的測試類型中，成品測試是最突出和最重要的部分。這是因為它直接影響最終分銷給消費者的藥品的品質、安全性和功效。 FDA 等監管機構要求對成品進行嚴格測試，以確保符合安全標準並確認其性能符合預期。隨著製藥公司努力滿足這些監管要求，成品測試外包成為確保市場效率和可靠性的關鍵策略。

醫藥分析測試外包市場-地理洞察

北美醫藥分析測試外包市場正在穩步成長，受藥物開發複雜性增加、成本最佳化需求以及測試技術進步等因素的推動。美國憑藉其強大的製藥業、高昂的醫療保健支出和完善的監管框架在該地區佔據主導地位。外包有助於公司管理成本、提高營運效率並獲得分析測試的專業知識。此外，對生物製藥和學名藥的需求不斷成長，推動了市場擴張。

該地區的主要參與者包括提供從穩定性測試到品質控制等廣泛服務的全球合約測試組織。隨著監管標準日益嚴格，製藥公司越來越依賴第三方服務來確保合規性並加快產品上市時間。由於製藥公司和外包供應商之間的合作趨勢日益增強，預計市場將繼續成長。

美國是北美醫藥分析測試外包市場的主導國家。它擁有全球最大的製藥產業，擁有許多領先的藥品製造商和生技公司。該國先進的醫療保健基礎設施、FDA 等監管機構以及對研發的高度重視推動了外包需求。美國製藥公司經常求助於合約測試組織來滿足監管要求並加快藥物開發流程，從而進一步鞏固其市場領導地位。

醫藥分析測試外包市場-競爭格局：

製藥分析測試外包市場的競爭格局以全球合約研究組織（CRO）、專業測試實驗室和大型製藥服務提供者的混合為特徵。 Labcorp Drug Development、Charles River Laboratories 和 Eurofins Scientific 等領導者憑藉其廣泛的測試服務組合和廣泛的地理覆蓋範圍佔據市場主導地位。公司正專注於透過高級資料分析和自動化等技術創新來增強其服務產品，以保持競爭優勢。

隨著企業尋求擴大其能力並改善服務交付，策略合作、合併和收購變得非常常見。此外，法規遵循和處理複雜藥物配方的能力也是關鍵的區別因素。規模較小且專注於特定領域的企業正在生物分析和專業測試服務領域中不斷開拓新市場。對更快、更具成本效益的測試解決方案的需求正推動公司採用更有效率的流程，從而進一步加劇競爭。

最新動態：

2023 年 12 月，Agno Pharma 收購了 Lubrizol Particle Sciences Inc.。此次收購涵蓋了 Particle Sciences Inc. 不可或缺的藥品配方技術，包括賓州伯利恆的開發和製造基地。

2023年11月，Eurofins收購了Quasfar，以支援拉丁美洲的製藥業，增強其研發能力，並在藥品開發的早期階段提供支援。

目錄

第1章：醫藥分析測試外包市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 醫藥分析測試外包市場片段（依服務類型）
    • 醫藥分析測試外包市場片段（依測試類型）
    • 醫藥分析測試外包市場片段（按最終用戶）
    • 藥品分析測試外包市場（按國家/地區）
    • 醫藥分析測試外包市場（按地區）
  • 競爭洞察

第3章：醫藥分析測試外包關鍵市場趨勢

  • 醫藥分析測試外包市場促進因素
    • 市場促進因素的影響分析
  • 醫藥分析測試外包市場限制
    • 市場限制的影響分析
  • 醫藥分析測試外包市場機會
  • 醫藥分析測試外包市場未來趨勢

第4章：產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：醫藥分析測試外包市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：醫藥分析測試外包市場格局

  • 2024年醫藥分析測試外包市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：醫藥分析測試外包市場-按服務類型

  • 概述
    • 按服務類型分類的細分市場佔有率分析
    • 品質控制測試
    • 生物分析測試
    • 穩定性測試
    • 方法開發和驗證
    • 監管測試
    • 微生物檢測

第8章：醫藥分析測試外包市場-按測試類型

  • 概述
    • 按測試類型進行細分佔有率分析
    • 原料檢測
    • 成品測試
    • 臨床試驗測試
    • 包裝測試

第9章：醫藥分析測試外包市場－按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 製藥公司
    • 生技公司
    • 合約研究組織（CRO）
    • 學術和研究機構
    • 政府和監管機構

第 10 章：醫藥分析測試外包市場-按地域

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美醫藥分析測試外包主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按服務類型）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲藥物分析測試外包主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按服務類型）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區醫藥分析測試外包主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依服務類型）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲藥物分析測試外包主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按服務類型）
    • 拉丁美洲市場規模及預測（依測試類型）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的藥物分析測試外包主要製造商
    • MEA市場規模及預測（依國家）
    • MEA市場規模及預測（依服務類型）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：關鍵供應商分析醫藥分析測試外包產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Labcorp Drug Development
    • Charles River Laboratories
    • WuXi AppTec
    • PPD (Pharmaceutical Product Development)
    • Eurofins Scientific
    • Intertek Group
    • Parexel International
    • Syneos Health
    • Catalent
    • Bioanalytical Systems, Inc. (BASi)
    • Patheon
    • Medpace
    • Pharmaceutical Product Development (PPD)
    • Aptuit
    • Toxikon
    • Frontage Laboratories
    • Covance
    • ICON plc

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4934

REPORT HIGHLIGHT

Pharmaceutical Analytical Testing Outsourcing Market size was valued at US$ 8,530.55 Million in 2024, expanding at a CAGR of 7.70% from 2025 to 2032.

The Pharmaceutical Analytical Testing Outsourcing Market refers to the growing trend of pharmaceutical companies outsourcing their analytical testing services to third-party organizations. These services involve testing the quality, safety, and efficacy of pharmaceutical products, including raw materials, formulations, and finished drugs. By outsourcing, companies can reduce operational costs, enhance efficiency, and access specialized expertise without investing heavily in in-house facilities. Key players in the market include contract research organizations (CROs) and independent testing labs. The market has seen growth due to increasing regulatory requirements, a rise in complex drug formulations, and a need for faster time-to-market. It also helps pharmaceutical companies manage resources effectively while maintaining high-quality standards. Global expansion and technological advancements are expected to drive further growth in this sector.

Pharmaceutical Analytical Testing Outsourcing Market- Market Dynamics

Expansion of generic drug markets boosting analytical testing needs

The expansion of the generic drug market is a significant driver for the pharmaceutical analytical testing outsourcing market. As the demand for affordable medications grows globally, particularly in North America, pharmaceutical companies increasingly focus on developing generic drugs, which requires stringent analytical testing to ensure quality and regulatory compliance. The generic drug industry benefits from lower production costs, and outsourcing analytical testing allows companies to maintain high standards while controlling expenses. Moreover, the increasing pressure to bring generics to market quickly further drives the need for outsourcing, as third-party testing providers offer speed and specialized expertise. According to the U.S. FDA, over 90% of prescriptions in the U.S. are filled with generics, highlighting the vast market size and the corresponding need for reliable and efficient testing. This trend is expected to continue, fueling demand for contract testing services in the coming years.

Pharmaceutical Analytical Testing Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.70% over the forecast period (2025-2032)

Based on Service Type segmentation, Quality Control Testing was predicted to show maximum market share in the year 2024

Based on Testing Type segmentation, Finished Product Testing was the leading Testing Type in 2024

Based on End-User segmentation, Pharmaceutical Companies was the leading End-User in 2024

On the basis of region, North America was the leading revenue generator in 2024

Pharmaceutical Analytical Testing Outsourcing Market- Segmentation Analysis:

The Global Pharmaceutical Analytical Testing Outsourcing Market is segmented on the basis of Service Type, Testing Type, End-User, and Region.

The market is divided into six categories based on Service Type: Quality Control Testing, Bioanalytical Testing, Stability Testing, Method Development and Validation, Regulatory Testing, and Microbiological Testing. In the Pharmaceutical Analytical Testing Outsourcing Market, Quality Control Testing is the most significant and dominant segment. This is due to its critical role in ensuring that pharmaceutical products meet the required standards of safety, efficacy, and quality before they reach the market. Quality control testing is mandatory throughout the drug development process and is essential for regulatory compliance, which makes it a key focus for outsourcing in the pharmaceutical industry. The increasing demand for high-quality, reliable products drives a continuous need for these services, further solidifying its prominence.

The market is divided into four categories based on Testing Type: Raw Material Testing, Finished Product Testing, Clinical Trial Testing, and Packaging Testing. Among the testing types in the Pharmaceutical Analytical Testing Outsourcing Market, Finished Product Testing is the most prominent and significant segment. This is because it directly impacts the quality, safety, and efficacy of the final pharmaceutical products that are distributed to consumers. Regulatory agencies, such as the FDA, require stringent testing of finished products to ensure compliance with safety standards and to confirm that they perform as intended. As pharmaceutical companies strive to meet these regulatory requirements, outsourcing of finished product testing becomes a key strategy to ensure efficiency and reliability in the market.

Pharmaceutical Analytical Testing Outsourcing Market- Geographical Insights

The North American pharmaceutical analytical testing outsourcing market is growing steadily, driven by factors such as increasing drug development complexity, the need for cost optimization, and advancements in testing technologies. The U.S. dominates the region due to its robust pharmaceutical industry, high healthcare expenditures, and well-established regulatory frameworks. Outsourcing helps companies manage costs, improve operational efficiency, and gain access to specialized expertise in analytical testing. Further, the rising demand for biopharmaceuticals and generics fuels market expansion.

Key players in the region include global contract testing organizations offering a wide range of services, from stability testing to quality control. As regulatory standards become stricter, pharmaceutical companies increasingly rely on third-party services to ensure compliance and accelerate time-to-market. The market is expected to witness continued growth due to the increasing trend of partnerships between pharmaceutical companies and outsourcing providers.

The United States is the dominant country in the North American pharmaceutical analytical testing outsourcing market. It boasts the largest pharmaceutical industry globally, with numerous leading drug manufacturers and biotech firms. The country's advanced healthcare infrastructure, regulatory bodies like the FDA, and strong emphasis on research and development drive the demand for outsourcing. U.S.-based pharmaceutical companies often turn to contract testing organizations to meet regulatory requirements and expedite drug development processes, further solidifying its market leadership.

Pharmaceutical Analytical Testing Outsourcing Market- Competitive Landscape:

The competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market is characterized by a mix of global contract research organizations (CROs), specialized testing labs, and large pharmaceutical service providers. Leading players like Labcorp Drug Development, Charles River Laboratories, and Eurofins Scientific dominate the market with their extensive portfolios of testing services and a broad geographical reach. Companies are focusing on enhancing their service offerings through technological innovations, such as advanced data analytics and automation, to stay ahead of the competition.

Strategic collaborations, mergers, and acquisitions are common as firms seek to expand their capabilities and improve service delivery. Additionally, regulatory compliance and the ability to handle complex drug formulations are key differentiators. Smaller and niche players are increasingly carving out specialized niches in bioanalytical and specialized testing services. The demand for faster, cost-effective testing solutions is pushing companies to adopt more efficient processes, further intensifying competition.

Recent Developments:

In December 2023, Agno Pharma acquired Lubrizol Particle Sciences Inc. The acquisition encompasses the drug product formulation technology integral to Particle Sciences Inc. including the PA, Bethlehem development & manufacturing site.

In November 2023, Eurofins acquired Quasfar supporting the pharmaceutical industry in Latin America, enhancing its capabilities in R&D, and providing support in the early stages of pharmaceutical product development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBALPHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Labcorp Drug Development
  • Charles River Laboratories
  • WuXi AppTec
  • PPD (Pharmaceutical Product Development)
  • Eurofins Scientific
  • Intertek Group
  • Parexel International
  • Syneos Health
  • Catalent
  • Bioanalytical Systems, Inc. (BASi)
  • Patheon
  • Medpace
  • Pharmaceutical Product Development (PPD)
  • Aptuit
  • Toxikon
  • Frontage Laboratories
  • Covance
  • ICON plc

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Quality Control Testing
  • Bioanalytical Testing
  • Stability Testing
  • Method Development and Validation
  • Regulatory Testing
  • Microbiological Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TESTING TYPE- MARKET ANALYSIS, 2019 - 2032

  • Raw Material Testing
  • Finished Product Testing
  • Clinical Trial Testing
  • Packaging Testing

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Government and Regulatory Bodies

GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Analytical Testing Outsourcing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Service Type
    • 2.1.2. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Testing Type
    • 2.1.3. Pharmaceutical Analytical Testing Outsourcing Market Snippet by End-User
    • 2.1.4. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Country
    • 2.1.5. Pharmaceutical Analytical Testing Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Analytical Testing Outsourcing Key Market Trends

  • 3.1. Pharmaceutical Analytical Testing Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Analytical Testing Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Analytical Testing Outsourcing Market Opportunities
  • 3.4. Pharmaceutical Analytical Testing Outsourcing Market Future Trends

4. Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Analytical Testing Outsourcing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Analytical Testing Outsourcing Market Landscape

  • 6.1. Pharmaceutical Analytical Testing Outsourcing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Analytical Testing Outsourcing Market - By Service Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service Type, 2024 & 2032 (%)
    • 7.1.2. Quality Control Testing
    • 7.1.3. Bioanalytical Testing
    • 7.1.4. Stability Testing
    • 7.1.5. Method Development and Validation
    • 7.1.6. Regulatory Testing
    • 7.1.7. Microbiological Testing

8. Pharmaceutical Analytical Testing Outsourcing Market - By Testing Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Type, 2024 & 2032 (%)
    • 8.1.2. Raw Material Testing
    • 8.1.3. Finished Product Testing
    • 8.1.4. Clinical Trial Testing
    • 8.1.5. Packaging Testing

9. Pharmaceutical Analytical Testing Outsourcing Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. Contract Research Organizations (CROs)
    • 9.1.5. Academic and Research Institutes
    • 9.1.6. Government and Regulatory Bodies

10. Pharmaceutical Analytical Testing Outsourcing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APACMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APACMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APACMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAMMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAMMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Analytical Testing Outsourcing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEAMarket Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEAMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. IsraelMarket Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. IsraelMarket Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. IsraelMarket Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Testing Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Analytical Testing Outsourcing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Labcorp Drug Development
    • 11.2.2. Charles River Laboratories
    • 11.2.3. WuXi AppTec
    • 11.2.4. PPD (Pharmaceutical Product Development)
    • 11.2.5. Eurofins Scientific
    • 11.2.6. Intertek Group
    • 11.2.7. Parexel International
    • 11.2.8. Syneos Health
    • 11.2.9. Catalent
    • 11.2.10. Bioanalytical Systems, Inc. (BASi)
    • 11.2.11. Patheon
    • 11.2.12. Medpace
    • 11.2.13. Pharmaceutical Product Development (PPD)
    • 11.2.14. Aptuit
    • 11.2.15. Toxikon
    • 11.2.16. Frontage Laboratories
    • 11.2.17. Covance
    • 11.2.18. ICON plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us